Masimo Corporation (MASI) Stock Score, Valuation & Financial Research
Masimo Corporation is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 31/100.
Quick answer for MASI
Masimo Corporation currently has a Wall Street Score of 31/100. The stored market price is $179.95. Its financial score is 16/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Masimo Corporation does
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, region
MASI financial snapshot
- Wall Street Score:
- 31/100
- Current price:
- $179.95
- Market capitalization:
- $9.42B
- Revenue:
- $1.56B
- Net income:
- $76.3M
- Free cash flow:
- $197.8M
- Cash:
- $124.6M
- Total debt:
- $485.9M
- EPS:
- -2.83
- Financial score:
- 16/100
- Valuation score:
- 0/100
- Revenue score:
- 7/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $197.8M, showing positive cash generation.
- The balance sheet shows $124.6M of cash versus $485.9M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 16/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MASI
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.